200 related articles for article (PubMed ID: 16579002)
1. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
2. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy.
Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M
Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
Vora JP; Leese GP; Peters JR; Owens DR
J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
[TBL] [Abstract][Full Text] [Related]
4. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
Tajiri Y; Umeda F; Inoguchi T; Kunisaki M; Nawata H; Ninomiya H; Asano T
Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
[TBL] [Abstract][Full Text] [Related]
6. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
Hay U; Ludvik B; Gisinger C; Schernthaner G
Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
[TBL] [Abstract][Full Text] [Related]
7. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Hopper AH; Tindall H; Davies JA
Nephrol Dial Transplant; 1989; 4(2):140-3. PubMed ID: 2496357
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients.
Ravid M; Savin H; Lang R; Jutrin I; Shoshana L; Lishner M
Arch Intern Med; 1992 Jun; 152(6):1225-9. PubMed ID: 1599351
[TBL] [Abstract][Full Text] [Related]
9. [The significance of determination of urinary type IV collagen concentrations from a random urine collection in patients with non-insulin dependent diabetes mellitus].
Kotajima N; Fukumura Y; Obata K; Kobayashi I
Rinsho Byori; 1998 Mar; 46(3):277-82. PubMed ID: 9564768
[TBL] [Abstract][Full Text] [Related]
10. [The nephroprotective effect of ramipril. Effect on blood pressure and metabolic control in insulin-treated patients with type-2 diabetes mellitus].
Jungmann E; Krüger K; Semler B; Haak T; Scherberich J; Schumm-Draeger PM; Usadel KH
Fortschr Med; 1994 Jan; 112(3):39-42. PubMed ID: 8144124
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of renal lesions with urinary protein excretion in patients with overt diabetic nephropathy].
Okada T; Matsumoto H; Nakao T; Nagaoka Y; Yamada C; Shino T; Yoshino M; Hidaka H; Han MG; Ootani M; Shimizu T
Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):475-85. PubMed ID: 10502941
[TBL] [Abstract][Full Text] [Related]
12. Renal function in adult Nigerian diabetics.
Arije A; Akinsola W; Ladipo GO
Trop Geogr Med; 1988 Oct; 40(4):334-7. PubMed ID: 3227554
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
[TBL] [Abstract][Full Text] [Related]
14. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
[TBL] [Abstract][Full Text] [Related]
15. Central role of TGF-beta in the pathogenesis of diabetic nephropathy and macrovascular complications: a hypothesis.
Yokoyama H; Deckert T
Diabet Med; 1996 Apr; 13(4):313-20. PubMed ID: 9162605
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
Guerrero-Romero F; Rodríguez-Morán M; Paniagua-Sierra JR; García-Bulnes G; Salas-Ramírez M; Amato D
Clin Nephrol; 1995 Feb; 43(2):116-21. PubMed ID: 7736673
[TBL] [Abstract][Full Text] [Related]
17. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
Bakris GL; Weir MR; DeQuattro V; McMahon FG
Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
[TBL] [Abstract][Full Text] [Related]
18. Effect of exercise on hemodynamics and urinary protein excretion in patients with early-stage diabetic nephropathy.
Kanauchi M; Ishii K; Nishiura K; Dohi K
Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):928-33. PubMed ID: 7933669
[TBL] [Abstract][Full Text] [Related]
19. [Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy].
Dedov II; Mukhin NA; Pal'tsev MA; Delektorskaia LN; Shestakova MV
Ter Arkh; 1989; 61(12):73-6. PubMed ID: 2629151
[TBL] [Abstract][Full Text] [Related]
20. alpha-Tocopherol reduces proteinuria, oxidative stress, and expression of transforming growth factor beta 1 in IgA nephropathy in the rat.
Chan W; Krieg RJ; Norkus EP; Chan JC
Mol Genet Metab; 1998 Mar; 63(3):224-9. PubMed ID: 9608545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
